SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-031625
Filing Date
2016-10-12
Accepted
2016-10-12 18:26:13
Documents
1
Period of Report
2016-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2773
  Complete submission text file 0000899243-16-031625.txt   4459
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address PILLAR PHARMACEUTICALS V LP OMAR DAOUK STREET BEIRUT E9 02210
Business Address PILLAR PHARMACEUTICALS V LP OMAR DAOUK STREET BEIRUT E9 02210 617-570-1496
Pillar Pharmaceuticals V LP (Reporting) CIK: 0001687312 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-31918 | Film No.: 161933842